Literature DB >> 19713597

Ultrasound contrast agents as markers of vascularity and microcirculation.

Christian Greis1.   

Abstract

Ultrasound contrast agents contain tiny gas-filled microbubbles which on intravenous injection are transported like red blood cells by the bloodstream. They are distributed to the entire macro- and microvascular system without extravasation (blood-pool tracer). Contrast-specific ultrasound modalities allow selective imaging of these microbubble contrast agents in real time, with excellent separation from underlying tissue signals. The dynamic wash-in and wash-out of a contrast bolus allows the detection and quantitative assessment of vascular flow and parenchymal perfusion. On complete filling of vascular structures the microbubble distribution delineates the vascular lumen and depicts the vascular architecture, down to tiny branches within parenchymal tissue. Mathematical models for bolus kinetics and flash/replenishment kinetics allow precise quantification of relative blood volume and blood flow, with high temporal and spatial resolution. Contrast-enhanced ultrasound examinations can be repeated at short intervals and performed at the bedside, making this diagnostic method convenient for guidance of interventions and therapy monitoring. Future applications include the use of microbubbles as target-specific molecular imaging agents and as delivery systems for local drug and gene therapies.

Mesh:

Substances:

Year:  2009        PMID: 19713597     DOI: 10.3233/CH-2009-1216

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  40 in total

1.  Intraductally applied contrast-enhanced ultrasound (IA-CEUS) for evaluating obstructive disease and secretory dysfunction of the salivary glands.

Authors:  Pamela Zengel; A Berghaus; C Weiler; M Reiser; D A Clevert
Journal:  Eur Radiol       Date:  2010-12-31       Impact factor: 5.315

Review 2.  [Possibilities of sonographic image fusion: Current developments].

Authors:  E M Jung; D-A Clevert
Journal:  Radiologe       Date:  2015-11       Impact factor: 0.635

3.  Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models.

Authors:  John R Eisenbrey; Christian C Wilson; Raymond J Ro; Traci B Fox; Ji-Bin Liu; See-Ying Chiou; Flemming Forsberg
Journal:  Ultrasonics       Date:  2013-04-12       Impact factor: 2.890

4.  [Summary of technical principles of contrast sonography and future perspectives].

Authors:  C Greis
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

5.  [Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma].

Authors:  E M Jung; W Uller; C Stroszczynski; D-A Clevert
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

6.  [Contrast-enhanced ultrasound in animal models].

Authors:  P M Paprottka; P Zengel; M Ingrisch; C C Cyran; M Eichhorn; M F Reiser; K Nikolaou; D-A Clevert
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

Review 7.  [Latest developments in ultrasound of the liver].

Authors:  D-A Clevert; A Helck; P M Paprottka; F Schwarz; M F Reiser
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

8.  CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results.

Authors:  A Helck; M Wessely; M Notohamiprodjo; U Schönermarck; E Klotz; M Fischereder; F Schön; K Nikolaou; D A Clevert; M Reiser; C Becker
Journal:  Eur Radiol       Date:  2013-05-10       Impact factor: 5.315

9.  [Preclinical imaging in animal models of radiation therapy].

Authors:  K Nikolaou; C C Cyran; K Lauber; M F Reiser; D-A Clevert
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

10.  [Management of salivary gland diseases with contrast-enhanced ultrasound].

Authors:  P Zengel; F Schrötzlmair; M Kramer; P Paprottka; D-A Clevert
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.